Marburg outbreak in Rwanda declared over
On Dec. 20, 2024, the World Health Organization (WHO) announced that the outbreak of Marburg Virus Disease was…
On Dec. 20, 2024, the World Health Organization (WHO) announced that the outbreak of Marburg Virus Disease was…
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
On Nov. 1, 2024, the World Health Organization reported that as of October 31, 66 confirmed cases, including…
On Oct. 25, 2024, the World Health Organization reported that as of October 24, a total of 64…
On Oct. 12, 2024, the Sabin Vaccine Institute announced it had delivered approximately 1,000 more investigational vaccine doses…
On Oct. 11, 2024, the World Health Organization (WHO) reported that a total of 58 cases of Marburg…
On Oct. 5, 2024, the Sabin Vaccine Institute announced it had provided its investigational Marburg vaccine to Rwanda…
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
On Jul. 15, 2024, the Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against…
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine…
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
On Jan. 16, 2022, the WHO announced that it had shipped 1.1 million COVID-19 vaccines to Rwanda on…
On Mar. 3, 2021, Pfizer and BioNTech, in partnership with UNICEF, announced the arrival of the first doses…
On Nov. 13, 2020, Albert Einstein College of Medicine announced that it had received a five-year, $4.9 million…